2022 Q1 Form 10-Q Financial Statement

#000182912622011676 Filed on May 23, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $150.0K $29.92K $2.477M
YoY Change -93.94% 28.14%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $150.0K $29.92K $2.477M
YoY Change -93.94% 28.14%
Operating Profit -$150.0K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$150.0K -$29.92K -$2.477M
YoY Change -93.94% 28.14%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$150.0K -$29.92K -$7.577K
YoY Change 1879.9% 28.14%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$9.086K -$2.073K -$4.769K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets $0.00
Total Assets $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.23K $5.961K $0.00
YoY Change 6.26%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $241.3K $108.6K $48.45K
YoY Change 398.06% 139.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $264.5K $114.5K $48.45K
YoY Change 446.01% 125.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $264.5K $114.5K $48.45K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $264.5K $114.5K $48.45K
YoY Change 446.01% 125.13%
SHAREHOLDERS EQUITY
Retained Earnings -$101.5M
YoY Change
Common Stock $16.51K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$264.5K -$114.5K -$48.45K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$150.0K -$29.92K -$7.577K
YoY Change 1879.9% 28.14%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$132.8K -$30.91K -$13.19K
YoY Change 906.44% 74.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 132.8K 30.91K 13.19K
YoY Change 906.44% 74.24%
NET CHANGE
Cash From Operating Activities -132.8K -30.91K -13.19K
Cash From Investing Activities
Cash From Financing Activities 132.8K 30.91K 13.19K
Net Change In Cash 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$132.8K -$30.91K -$13.19K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Assets
Assets
USD
CY2021Q4 us-gaap Assets
Assets
USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
USD
CY2022Q1 us-gaap Revenues
Revenues
USD
CY2021Q1 us-gaap Revenues
Revenues
USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD

Files In Submission

Name View Source Status
0001829126-22-011676-index-headers.html Edgar Link pending
0001829126-22-011676-index.html Edgar Link pending
0001829126-22-011676.txt Edgar Link pending
0001829126-22-011676-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
winvestgroup_10q.htm Edgar Link pending
winvestgroup_10q_htm.xml Edgar Link completed
winvestgroup_ex31-1.htm Edgar Link pending
winvestgroup_ex31-2.htm Edgar Link pending
winvestgroup_ex32-1.htm Edgar Link pending
winvestgroup_ex32-2.htm Edgar Link pending
wnlv-20220331.xsd Edgar Link pending
wnlv-20220331_cal.xml Edgar Link unprocessable
wnlv-20220331_def.xml Edgar Link unprocessable
wnlv-20220331_lab.xml Edgar Link unprocessable
wnlv-20220331_pre.xml Edgar Link unprocessable